Drug Safety

Negative Effects of Antiepileptic Drugs on Mood in Patients with Epilepsy
pp. 555-567(13)
Authors: Mula, Marco; Sander, Josemir W.

Safety and Usage of Atypical Antipsychotic Medicines in Children: A Nationwide Prospective Cohort Study
pp. 569-579(11)
Authors: Harrison-Woolrych, Mira; Garcia-Quiroga, Juan; Ashton, Janelle; Herbison, Peter

An Observational Study of Cholecystectomy in Patients Receiving Tegaserod
pp. 581-588(8)
Authors: Brinker, Allen; Schech, Stephanie D.; Burgess, Margaret; Avigan, Mark

Risk of Diabetic Ketoacidosis after Exposure to Risperidone or Olanzapine
pp. 589-599(11)
Authors: Ramaswamy, Krishnan; Kozma, Chris M.; Nasrallah, Henry

Thoughts on Signal Detection in Pharmacovigilance
pp. 603-606(4)
Author: Shakir, Saad A.W.

Signal Detection: Historical Background
pp. 607-609(3)
Author: Egberts, Toine C.G.

Epidemiological Context of Signalling
pp. 611-613(3)
Author: Stang, Paul

You've Found a Safety Signal - Now What?: Regulatory Implications of Industry Signal Detection Activities
pp. 615-616(2)
Author: Kahn, Sidney N.

Standardised MedDRA Queries: Their Role in Signal Detection
pp. 617-619(3)
Author: Mozzicato, Patricia

Principles of Data Mining
pp. 621-622(2)
Author: Hand, David J.

Bayesian Confidence Propagation Neural Network
pp. 623-625(3)
Author: Bate, Andrew

Signal Detection in the Pharmaceutical Industry: Integrating Clinical and Computational Approaches
pp. 627-630(4)
Author: Hauben, Manfred

Innovations for the Future of Pharmacovigilance
pp. 631-633(3)
Author: Almenoff, June S.

Use of Triage Strategies in the WHO Signal-Detection Process
pp. 635-637(3)
Author: Lindquist, Marie

Prescription-Event Monitoring: Developments in Signal Detection
pp. 639-641(3)
Author: Ferreira, Germano

Use of Contemporary Antidepressants during Breastfeeding
pp. 643-643(1)
Authors: Einarson, Adrienne; Ito, Shinya

The Author's Reply
pp. 643-644(2)
Author: Gentile, Salvatore